Rivamed Secures Tens of Millions of RMB in Series A Funding from YUEIN Healthcare Fund to Advance Medical IoT and Big Data Solutions

Recently, Ruihua Kangyuan, a leading domestic provider of medical Internet of Things (IoT) and big data services, officially announced the completion of its Series A financing round, raising tens of millions of RMB. Yueyin Medical Fund served as the sole investor in this round. The proceeds will be primarily used for new product research and development and the establishment of a nationwide service system.

A review of the portfolio companies previously invested in by Yueyin Medical Fund—including Kaipu Imaging, Zhenluo Technology, Genetron Health, Puerui Biotechnology, Mingyi Zhudao, The Lancet Doctor, Shuchuang Robotics, and Meiermu Ophthalmology—reveals a consistent adherence to the same “focus on specialization” logic.

China’s healthcare informatics market is expanding rapidly, with a compound annual growth rate (CAGR) exceeding 11% and a current market size approaching RMB 30 billion. The construction of traditional hospital information systems in China has been initially established, and the application of the Medical Internet of Things (MIoT) and big data will become the prevailing trend in hospital informatization.

Ruihua Kangyuan specializes in the development of medical Internet of Things (IoT) infrastructure and big data analytics. Targeting core hospital operational scenarios—specifically operating rooms and patient wards—the company provides comprehensive smart healthcare solutions that integrate software, hardware, and electromechanical systems. Its product portfolio spans multiple lines, including medication management, consumables management, operating room management, and logistics robot management. All business systems are deeply integrated with hospital information systems, creating a unified intelligent IoT information service platform. As a result, Ruihua Kangyuan has become one of the enterprises in China with the most extensive coverage of medical IoT products.

The company’s products have been deployed in dozens of large Grade 3A hospitals, including Peking Union Medical College Hospital, the Chinese PLA General Hospital (301 Hospital), Peking University Cancer Hospital, Beijing Fuwai Hospital, Beijing Tiantan Hospital, Beijing Chaoyang Hospital, Shandong Qianfoshan Hospital, Shenzhen People’s Hospital, and the Second Affiliated Hospital of Lanzhou University, establishing the company as a leading enterprise in China’s medical Internet of Things (IoT) sector.

Ruihua Kangyuan Digital Operating Room and Intelligent Narcotic and Psychotropic Drug Management Cart

Regarding this round of investment, Ms. Zheng Yufen, Managing Partner of Yueyin Medical Fund, stated candidly, “As an investment firm dedicated to the healthcare industry, we have invested in nearly 20 leading medical enterprises across various specialized sectors. The future direction of healthcare informatization lies in intelligence and the Internet of Things (IoT). In addition to recognizing the significant potential within the niche fields of medical IoT and big data, our greatest confidence stems from the founding team. Notably, the founder, Shi Danjie, has over two decades of experience in the healthcare industry. A graduate of Stanford Graduate School of Business, he amassed nearly ten years of corporate management and product development experience at Covidien, a renowned U.S. medical device company, and has successfully established multiple high-tech enterprises. We are delighted to participate in Ruihua Kangyuan’s current financing round and aspire to serve as the team’s ‘capital partner,’ contributing to the advancement of healthcare services in China!”

Mr. Shi Danjie, founder of Ruihua Kangyuan, stated: “The Internet of Medical Things (IoMT) has been widely adopted in developed countries such as the United States, with some major international players also establishing a presence in China. Against the backdrop of China’s new healthcare reforms, driven by policies such as the zero-markup policy for pharmaceuticals and significant price reductions for medical consumables, there is a growing demand for standardized, intelligent, and lean hospital supply chain management. The company’s vision is to leverage IoT and big data technologies to help hospitals deliver safe, cost-effective, and high-quality medical services, ultimately benefiting patients.”

“At its inception, the company started with a controlled substance management system for operating rooms. It has since developed multiple intelligent systems covering pharmaceuticals, consumables, personnel, and robotics, along with dozens of sub-products. By building an IoT-based unified information service platform leveraging artificial intelligence and big data analytics, the company has achieved refined, closed-loop management of the entire lifecycle of medical supplies, ensuring they are traceable, controllable, and fully visible.”

Application Scenarios of Ruihua Kangyuan Intelligent Logistics Robots at Fuwai Hospital

“Over the next three to five years, we aim to become a leading provider in China and a world-class supplier of medical AIoT solutions.” Founder Shi Danjie is firm and clear about the company’s development goals.